Data
Lookout
Search
Browse
Diseases
Sponsors
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
Sign In
Home
NCT07215936
Clinical Trial
Dose-dense Capecitabine Schedule [7days on _7 Days Off] in Colorectal Cancer in Comparison With Standered Regimen
Active, Not Recruiting
Phase 2
View on ClinicalTrials.gov →
Summary
Dose\_dense Capecitabine Schedule in colorectal cancers
Trial Details
NCT Number
NCT07215936
Lead Sponsor
Sohag University
Conditions
Colorectal Cancer
Enrollment
100 participants
Start Date
2025-09-25
Primary Completion
2027-09
(estimated)
Study Completion
2028-09
(estimated)
Updated on ClinicalTrials.gov
2025-10-14